Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.45 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | NR1H4 | Q96RI1 | 7/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6521104 | 0.91 | ALDH1A1 (0.39) | HCAR2RAB9AALDH1A1LMNATHRB | |
| SCHEMBL6515419 | 0.89 | CES2 (0.39) | RAB9AALDH1A1LMNATHRBHTT | |
| SCHEMBL6523557 | 0.85 | ATM (0.37) | HCAR2RAB9AALDH1A1LMNATHRB | |
| SCHEMBL6519734 | 0.85 | HCAR2 (0.47) | HCAR2ALDH1A1LMNATHRBMEN1 | |
| SCHEMBL6523452 | 0.81 | EPHX1 (0.34) | RAB9AALDH1A1LMNATHRBHTT | |
| SCHEMBL6513751 | 0.80 | EPHX1 (0.37) | RAB9AALDH1A1LMNATHRBHTT | |
| SCHEMBL6523997 | 0.80 | EPHX1 (0.37) | RAB9AALDH1A1LMNATHRBHTT | |
| SCHEMBL6520377 | 0.80 | ATM (0.59) | HCAR2RAB9AALDH1A1HTTSMN1; SMN2 | |
| SCHEMBL6523073 | 0.79 | ALDH1A1 (0.39) | HCAR2RAB9AALDH1A1LMNATHRB | |
| SCHEMBL6516594 | 0.77 | HCAR2 (0.42) | HCAR2KEAP1NFE2L2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | HCAR2 3143/4885KEAP1 1276/4885NFE2L2 2412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.